ARTICLE
16 December 2022

Holland & Knight Health Dose: December 13, 2022

HK
Holland & Knight

Contributor

Holland & Knight is a global law firm with nearly 2,000 lawyers in offices throughout the world. Our attorneys provide representation in litigation, business, real estate, healthcare and governmental law. Interdisciplinary practice groups and industry-based teams provide clients with access to attorneys throughout the firm, regardless of location.
Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.
United States Food, Drugs, Healthcare, Life Sciences

Holland & Knight Health Dose is an in-depth weekly dose of legislative and regulatory insights to keep stakeholders abreast of happenings in Washington, D.C., impacting the health sector.

This week's topics include:

  • Congress This Week: Federal Funding Cliff Fast Approaching; Another Short-Term CR Looks Increasingly Likely
  • Congressional Lawmakers Try to Drum Up Support to Stop Medicare Physician Cuts
  • Democratic Leadership Elections, Sinema Party Switch
  • CMS Issues Proposed Rule on Prior Authorization
  • Proposed FDA Rule Would Align Annual Safety Reporting with International Standards
  • ARPA-H Director Predicts Programs to Start Rolling Out in Q3 2023
  • Quick Shots

Read the full Health Dose

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More